GlassScriptPhysician profile
Robert G Blackwell
NPI 1700878865
$1,098.91
in general payments reported to CMS, 2019-2025
16 companies · $20.25 in 2025
The $20.25 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $117 · 2021: $410 · 2023: $51.88 · 2024: $30.42 · 2025: $20.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $239.29 | 2021 | |
| Pfizer INC. | $231.10 | 2019-2021 | |
| Abbvie INC. | $166.27 | 2019-2021 | |
| Astellas Pharma US INC | $89.66 | 2019-2025 | Veozah |
| Medtronic Vascular, INC. | $77.87 | 2019 | |
| Amag Pharmaceuticals, INC. | $66.52 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.24 | 2019 | |
| Duchesnay USA Incorporated | $34.28 | 2019 | |
| Fisher Scientific Company L.L.C. | $32.69 | 2019 | |
| Sumitomo Pharma America, INC. | $25.92 | 2023 | Myfembree |
| Exeltis, USA INC. | $18.87 | 2021 | |
| Merck Sharp & Dohme LLC | $18.86 | 2019 | |
| Hologic Sales and Service, LLC | $18.53 | 2019 | |
| Therapeuticsmd, INC. | $11.22 | 2021 | |
| Boston Scientific Corporation | $11.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $6.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Blackwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.